Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 GBX | +1.75% | +1.75% | +16.00% |
Apr. 03 | Allergy Therapeutics Announces Resignation of Mary Tavener as Non-Executive Director | CI |
Mar. 27 | EARNINGS AND TRADING: Solid State ups outlook; Quartix trading in line | AN |
Sales 2022 | 72.77M 91.05M | Sales 2023 | 59.59M 74.56M | Capitalization | 7.13M 8.92M |
---|---|---|---|---|---|
Net income 2022 | -13M -16.27M | Net income 2023 | -43M -53.81M | EV / Sales 2022 | 1.7 x |
Net cash position 2022 | 9.99M 12.5M | Net Debt 2023 | 21.14M 26.46M | EV / Sales 2023 | 0.47 x |
P/E ratio 2022 |
-9.69
x | P/E ratio 2023 |
-0.16
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 6.79% |
1 day | +1.75% | ||
1 week | +1.75% | ||
Current month | -3.33% | ||
1 month | +5.45% | ||
3 months | +45.00% | ||
6 months | +110.14% | ||
Current year | +16.00% |
Managers | Title | Age | Since |
---|---|---|---|
Manuel Llobet
CEO | Chief Executive Officer | 60 | 09-06-30 |
Shaun Furlong
DFI | Director of Finance/CFO | - | 22-03-31 |
Murray Skinner
CTO | Chief Tech/Sci/R&D Officer | - | 03-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 17-06-05 | |
Peter Jensen
CHM | Chairman | 73 | 10-09-30 |
Anthony Parker
BRD | Director/Board Member | - | 22-12-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 2.9 | +1.75% | 745 483 |
24-04-24 | 2.85 | +1.79% | 919,062 |
24-04-23 | 2.8 | -1.75% | 948,754 |
24-04-22 | 2.85 | +7.55% | 668,040 |
24-04-19 | 2.65 | -7.02% | 1,429,952 |
Delayed Quote London S.E., April 25, 2024 at 06:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+16.00% | 169M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.40% | 22.2B | |
-16.53% | 21.23B | |
-8.86% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- AGY Stock